Free Trial

Organogenesis (ORGO) Earnings Date, Estimates & Call Transcripts

Organogenesis logo
$2.77
-0.12 (-4.15%)
(As of 10/31/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 12
After Market Closes
Confirmed
Actual EPS
(Aug. 8)
-$0.13 Missed By -$0.11
Consensus EPS
(Aug. 8)
-$0.02
Skip Charts & View Estimated and Actual Earnings Data

ORGO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ORGO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Organogenesis Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.17) EPS
Next Year EPS Consensus Estimate: $0.01 EPS

ORGO Earnings Date and Information

Organogenesis last released its earnings data on August 8th, 2024. The reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.11. The business had revenue of $130.23 million for the quarter, compared to the consensus estimate of $122.48 million. Organogenesis has generated $0.04 earnings per share over the last year ($0.04 diluted earnings per share). Earnings for Organogenesis are expected to grow in the coming year, from ($0.17) to $0.01 per share. Organogenesis has confirmed that its next quarterly earnings report will be published on Tuesday, November 12th, 2024. Organogenesis will be holding an earnings conference call on Tuesday, November 12th at 5:00 PM Eastern. Interested parties can register for or listen to the call..

Organogenesis Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/12/2024
(Confirmed)
-------  
8/8/2024Q2 2024($0.02)($0.13)($0.11)($0.13)$122.48 million$130.23 million
5/9/2024Q1 2024($0.03)($0.02)+$0.01($0.02)$100.44 million$109.98 million      
11/9/2023Q3 2023$0.01$0.02+$0.01$0.02$112.75 million$108.53 million  
8/9/2023Q2 2023$0.02$0.04+$0.02$0.04$115.25 million$117.32 million  
5/10/2023Q1 2023-($0.02)($0.02)($0.02)-$107.64 million  
3/1/2023Q4 2022-$0.06+$0.06$0.06-$115.52 million  
11/9/2022Q3 2022$0.06$0.04($0.02)$0.08$121.40 million$116.86 million  
8/9/2022Q2 2022$0.08$0.09+$0.01$0.11$121.00 million$121.40 million  
5/10/2022Q1 2022$0.05$0.01($0.04)$0.02$96.15 million$98.12 million    
3/1/2022Q4 2021$0.08$0.41+$0.33$0.43$124.35 million$128.56 million
11/9/2021Q3 2021$0.06$0.09+$0.03$0.09$112.10 million$113.75 million    
8/9/2021Q2 2021$0.06$0.15+$0.09$0.15$105.65 million$123.20 million    
5/10/2021Q1 2021($0.04)$0.07+$0.11$0.07$86.30 million$102.55 million  
3/15/2021Q4 2020$0.12$0.15+$0.03$0.15$105.30 million$106.81 million  
11/9/2020Q3 2020($0.08)$0.19+$0.27$0.19$99.50 million$100.80 million  
8/10/2020Q2 2020($0.12)($0.05)+$0.07($0.05)$68.30 million$68.96 million  
5/11/2020Q1 2020($0.13)($0.16)($0.03)($0.16)$61.30 million$61.73 million  
3/9/2020Q4 2019($0.09)($0.04)+$0.05($0.04)-$74.65 million  
11/12/2019Q3($0.13)($0.12)+$0.01($0.12)$64.00 million$64.27 million  

Organogenesis Earnings - Frequently Asked Questions

When is Organogenesis's earnings date?

Organogenesis has confirmed that its next quarterly earnings data will be published on Tuesday, November 12th, 2024. Learn more on ORGO's earnings history.

What guidance has Organogenesis issued on next quarter's earnings?

Organogenesis updated its FY 2024 earnings guidance on Thursday, August, 8th. The company issued revenue guidance of $445.0 million-$470.0 million, compared to the consensus revenue estimate of $455.9 million.

Did Organogenesis beat their earnings estimates last quarter?

In the previous quarter, Organogenesis (NASDAQ:ORGO) missed the analysts' consensus estimate of ($0.02) by $0.11 with a reported earnings per share (EPS) of ($0.13). Learn more on analysts' earnings estimate vs. ORGO's actual earnings.

How much revenue does Organogenesis generate each year?

Organogenesis (NASDAQ:ORGO) has a recorded annual revenue of $448.39 million.

How much profit does Organogenesis generate each year?

Organogenesis (NASDAQ:ORGO) has a recorded net income of $4.95 million. ORGO has generated $0.04 earnings per share over the last four quarters.

What is Organogenesis's EPS forecast for next year?

Organogenesis's earnings are expected to grow from ($0.17) per share to $0.01 per share in the next year.


`

More Earnings Resources from MarketBeat


This page (NASDAQ:ORGO) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners